Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
In oncology precision medicine, focusing on early tumor screening and companion diagnosis
Innovative Solution
ChosenMed is a healthcare company in oncology precision medicine, focusing on early tumor screening and companion diagnosis.
Investment Funding
Last Funding Stage
Series C
Total Funding Amount
14.M
Last Funding Date
08-10-2021
Startup Stage
Late Stage Venture
Lead Investors
Highlight Capital, Med-Fine Capital, QS Capital, HY Capital, Yijing Capital
Revenue
$1M to $10M
People
Founders
Qiming Zhou
About
ChosenMed is a healthcare company in oncology precision medicine, focusing on early tumor screening and companion diagnosis.
Something missing or incorrect on this page? Help us enrich this information
